These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 31616949)
41. Evaluation of a dengue IgG indirect enzyme-linked immunosorbent assay and a Japanese encephalitis IgG indirect enzyme-linked immunosorbent assay for diagnosis of secondary dengue virus infection. Inoue S; Alonzo MT; Kurosawa Y; Mapua CA; Reyes JD; Dimaano EM; Alera MT; Saito M; Oishi K; Hasebe F; Matias RR; Natividad FF; Morita K Vector Borne Zoonotic Dis; 2010 Mar; 10(2):143-50. PubMed ID: 19874185 [TBL] [Abstract][Full Text] [Related]
42. Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections. Tyson J; Tsai WY; Tsai JJ; Brites C; Mässgård L; Ha Youn H; Pedroso C; Drexler JF; Stramer SL; Balmaseda A; Harris E; Wang WK J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429254 [TBL] [Abstract][Full Text] [Related]
43. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571 [TBL] [Abstract][Full Text] [Related]
44. Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. Felix AC; Souza NCS; Figueiredo WM; Costa AA; Inenami M; da Silva RMG; Levi JE; Pannuti CS; Romano CM J Med Virol; 2017 Aug; 89(8):1477-1479. PubMed ID: 28229481 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of serological cross-reactivity between yellow fever and other flaviviruses. Souza NCSE; Félix AC; de Paula AV; Levi JE; Pannuti CS; Romano CM Int J Infect Dis; 2019 Apr; 81():4-5. PubMed ID: 30660799 [TBL] [Abstract][Full Text] [Related]
46. Comparison of two rapid diagnostic tests during a large dengue virus serotype 3 outbreak in the Solomon Islands in 2013. Liu LT; Dalipanda T; Jagilly R; Wang YH; Lin PC; Tsai CY; Lai WT; Tsai JJ PLoS One; 2018; 13(8):e0202304. PubMed ID: 30096193 [TBL] [Abstract][Full Text] [Related]
47. [Flavivirus seroepidemiology in blood donors in Mersin province, Turkey]. Tezcan S; Kızıldamar S; Ulger M; Aslan G; Tiftik N; Ozkul A; Emekdaş G; Niedrig M; Ergünay K Mikrobiyol Bul; 2014 Oct; 48(4):606-17. PubMed ID: 25492656 [TBL] [Abstract][Full Text] [Related]
48. Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults. Kirstein J; Douglas W; Thakur M; Boaz M; Papa T; Skipetrova A; Plennevaux E BMC Infect Dis; 2018 Sep; 18(1):475. PubMed ID: 30241510 [TBL] [Abstract][Full Text] [Related]
49. Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction. Plennevaux E; Sabchareon A; Limkittikul K; Chanthavanich P; Sirivichayakul C; Moureau A; Boaz M; Wartel TA; Saville M; Bouckenooghe A Vaccine; 2016 May; 34(24):2707-12. PubMed ID: 27102820 [TBL] [Abstract][Full Text] [Related]
50. Monoclonal antibody-based capture ELISA in the diagnosis of previous dengue infection. Sirivichayakul C; Limkittikul K; Chanthavanich P; Yoksan S; Ratchatatat A; Lim JK; Arunsodsai W; Sabchareon A Virol J; 2019 Oct; 16(1):125. PubMed ID: 31665014 [TBL] [Abstract][Full Text] [Related]
52. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Houghton-Triviño N; Montaña D; Castellanos J Rev Salud Publica (Bogota); 2008; 10(2):299-307. PubMed ID: 19039426 [TBL] [Abstract][Full Text] [Related]
53. Methods to discriminate primary from secondary dengue during acute symptomatic infection. Nguyen THT; Clapham HE; Phung KL; Nguyen TK; DInh TT; Nguyen THQ; Tran VN; Whitehead S; Simmons C; Wolbers M; Wills B BMC Infect Dis; 2018 Aug; 18(1):375. PubMed ID: 30086716 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. Schwartz E; Mileguir F; Grossman Z; Mendelson E J Clin Virol; 2000 Dec; 19(3):169-73. PubMed ID: 11090753 [TBL] [Abstract][Full Text] [Related]
55. Development of a Rapid Diagnostic Test Kit to Detect IgG/IgM Antibody against Zika Virus Using Monoclonal Antibodies to the Envelope and Non-structural Protein 1 of the Virus. Kim YH; Lee J; Kim YE; Chong CK; Pinchemel Y; Reisdörfer F; Coelho JB; Dias RF; Bae PK; Gusmão ZPM; Ahn HJ; Nam HW Korean J Parasitol; 2018 Feb; 56(1):61-70. PubMed ID: 29529852 [TBL] [Abstract][Full Text] [Related]
56. The comparative accuracy of 8 commercial rapid immunochromatographic assays for the diagnosis of acute dengue virus infection. Blacksell SD; Newton PN; Bell D; Kelley J; Mammen MP; Vaughn DW; Wuthiekanun V; Sungkakum A; Nisalak A; Day NP Clin Infect Dis; 2006 Apr; 42(8):1127-34. PubMed ID: 16575730 [TBL] [Abstract][Full Text] [Related]
57. Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study. Tsai JJ; Tsai CY; Lin PC; Chen CH; Tsai WY; Dai YC; Lin YC; Pedroso C; Brites C; Wang WK BMC Infect Dis; 2023 May; 23(1):301. PubMed ID: 37158835 [TBL] [Abstract][Full Text] [Related]
58. Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus. Dayan GH; Langevin E; Forrat R; Zambrano B; Noriega F; Frago C; Bouckenooghe A; Machabert T; Savarino S; DiazGranados CA Vaccine; 2020 Sep; 38(41):6472-6477. PubMed ID: 32773243 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of the MRL diagnostics dengue fever virus IgM capture ELISA and the PanBio Rapid Immunochromatographic Test for diagnosis of dengue fever in Jamaica. Palmer CJ; King SD; Cuadrado RR; Perez E; Baum M; Ager AL J Clin Microbiol; 1999 May; 37(5):1600-1. PubMed ID: 10203534 [TBL] [Abstract][Full Text] [Related]